Alaska Permanent Fund’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-93,699
Closed -$9.98M 176
2025
Q1
$9.98M Hold
93,699
0.14% 72
2024
Q4
$8.65M Hold
93,699
0.13% 76
2024
Q3
$7.86M Hold
93,699
0.12% 85
2024
Q2
$7.13M Sell
93,699
-30,093
-24% -$2.01M 0.11% 90
2024
Q1
$9.07M Sell
123,792
-53,586
-30% -$4.12M 0.13% 77
2023
Q4
$14.4M Sell
177,378
-25,031
-12% -$1.95M 0.24% 39
2023
Q3
$15.2M Buy
202,409
+3,391
+2% +$261K 0.29% 34
2023
Q2
$15.3M Buy
+199,018
New +$15.9M 0.3% 32
2022
Q4
$15.2M Sell
177,321
-10,571
-6% -$837K 0.25% 28
2022
Q3
$11.6M Buy
187,892
+28,226
+18% +$1.78M 0.21% 26
2022
Q2
$9.87M Buy
159,666
+116,393
+269% +$7.21M 0.14% 37
2022
Q1
$2.57M Buy
43,273
+217
+0.5% +$13.9K 0.04% 114
2021
Q4
$2.96M Buy
43,056
+4,956
+13% +$341K 0.05% 57
2021
Q3
$2.66M Hold
38,100
0.05% 65
2021
Q2
$2.62M Buy
38,100
+3,300
+9% +$220K 0.05% 50
2021
Q1
$2.25M Hold
34,800
0.04% 202
2020
Q4
$2.03M Hold
34,800
0.04% 203
2020
Q3
$2.2M Buy
34,800
+18,900
+119% +$1.31M 0.04% 122
2020
Q2
$1.22M Hold
15,900
0.02% 38
2020
Q1
$1.19M Buy
+15,900
New +$1.1M 0.02% 33

Other funds holding GILD

Alaska Permanent Fund's GILD Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 93,699 shares — an estimated $9.98M sold.

Alaska Permanent Fund first reported a position in GILD in Q1 2020 and held it in 20 quarters. The position peaked at $15.3M in Q2 2023. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Alaska Permanent Fund reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Alaska Permanent Fund sold 93,699 Gilead Sciences shares in Q2 2025, an estimated $9.98M.
  • Alaska Permanent Fund first reported a position in Gilead Sciences in Q1 2020 and held it in 20 quarters.
  • Alaska Permanent Fund's Gilead Sciences position peaked at $15.3M in Q2 2023.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.